Coeptis Therapeutics Holdings, Inc.
COEP
$13.21
-$0.445-3.26%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 2.99M | 4.27M | 532.90K | 1.14M | 1.56M |
Total Receivables | 30.00K | -- | -- | -- | 191.10K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 677.60K | 382.60K | 518.40K | 227.20K | 244.80K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 3.69M | 4.65M | 1.05M | 1.36M | 1.99M |
|
|||||
Total Current Assets | 3.69M | 4.65M | 1.05M | 1.36M | 1.99M |
Net Property, Plant & Equipment | 49.70K | 60.10K | 70.20K | 80.20K | 90.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 1.51M | 496.70K | 541.90K | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | 1.30M | 1.55M | 1.82M | 2.12M |
Total Assets | 12.19M | 13.45M | 8.91M | 8.96M | 4.20M |
|
|||||
Total Accounts Payable | 1.03M | 1.12M | 1.27M | 1.13M | 1.28M |
Total Accrued Expenses | 416.20K | 602.40K | 736.90K | 742.20K | 771.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.16M | 1.87M | 1.23M | 1.56M | 1.57M |
Total Finance Division Other Current Liabilities | 1.87M | 2.06M | 1.28M | -- | -- |
Total Other Current Liabilities | 1.87M | 2.06M | 1.28M | -- | -- |
Total Current Liabilities | 4.48M | 5.65M | 4.51M | 3.44M | 3.63M |
|
|||||
Total Current Liabilities | 4.48M | 5.65M | 4.51M | 3.44M | 3.63M |
Long-Term Debt | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 18.90K | 18.90K | 18.90K | 61.20K | 61.20K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 467.30K | 169.10K | 359.30K | 322.10K | 671.60K |
Total Liabilities | 5.11M | 5.99M | 5.04M | 3.97M | 4.51M |
|
|||||
Common Stock & APIC | 111.85M | 108.38M | 102.98M | 102.15M | 100.50M |
Retained Earnings | -105.99M | -101.65M | -98.23M | -95.22M | -93.39M |
Treasury Stock & Other | 234.00K | -250.00K | -1.56M | -2.10M | -7.55M |
Total Common Equity | 6.10M | 6.48M | 3.19M | 4.82M | -442.60K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | -- |
|
|||||
Total Common Equity | 6.10M | 6.48M | 3.19M | 4.82M | -442.60K |
Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | -- |
Total Minority Interest | 984.30K | 984.30K | 682.10K | 157.70K | 132.50K |
Total Equity | 7.08M | 7.46M | 3.87M | 4.98M | -310.10K |
|